GREGOR BENDER, CEO and Co-founder, IMRSV Insights

Gregor Bender, Pharm.D., is the CEO and Co-founder of IMRSV Insights, where he leads innovations in decentralized and personalized pragmatic clinical trials. With experience at major pharmaceutical companies, including Pfizer, GSK, and Wyeth, Gregor has specialized in pharmacometric modeling and simulation across various therapeutic areas in preclinical and clinical research. He holds a Pharm.D. from the University of Pittsburgh and completed a prestigious postdoctoral fellowship at the Leiden/Amsterdam Center for Drug Research.

Under his leadership, IMRSV Insights aims to revolutionize the industry through AI-driven spatial computing solutions, enhancing cost management, improving patient access, and enabling pharmaceutical companies to leverage real-world data. His work aims to reduce the costs of clinical research while empowering individuals with efficient solutions that deliver actionable insights to drive personalized healthcare.